3.00
                                            
            Calcimedica Inc stock is traded at $3.00, with a volume of 4,030.
            It is up +0.33% in the last 24 hours and down -2.46% over the past month.
            CalciMedica Inc is a clinical-stage biopharmaceutical company focused on developing therapeutics that treat serious illnesses driven by inflammatory and immunologic processes and direct cellular damage. Its product candidates act upon calcium release-activated calcium (CRAC) channels and would constitute a new class of drugs. Its product candidate is Auxora, a potent and selective intravenous formulated small molecule CRAC channel inhibitor containing the active compound zegocractin (formerly referred to as CM4620) that, in animal models, reduced acute epithelial and/or endothelial cell injury and inflammation in organs, such as the pancreas, lungs and kidneys.
        
        See More
    Previous Close:
              $2.99
            Open:
              $3.03
            24h Volume:
                4,030
            Relative Volume:
              0.07
            Market Cap:
                $41.71M
            Revenue:
              -
            Net Income/Loss:
              $-20.87M
            P/E Ratio:
              -1.8839
            EPS:
                -1.5924
            Net Cash Flow:
                $-21.21M
            1W Performance:
              -0.20%
            1M Performance:
              -2.46%
            6M Performance:
                +91.08%
            1Y Performance:
              -18.92%
            Calcimedica Inc Stock (CALC) Company Profile
Name
                  
                      Calcimedica Inc
                    
                Sector
                  Industry
                  Phone
                  
                      858-952-5500
                    
                Address
                  
                      505 COAST BOULEVARD SOUTH, LA JOLLA
                    
                Compare CALC with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS | 
|---|---|---|---|---|---|---|
|   
                          
                                CALC
                            
                             Calcimedica Inc | 2.985 | 41.78M | 0 | -20.87M | -21.21M | -1.5924 | 
|   
                          
                                VRTX
                            
                             Vertex Pharmaceuticals Inc | 422.76 | 107.66B | 11.39B | 3.64B | 3.50B | 13.99 | 
|   
                          
                                REGN
                            
                             Regeneron Pharmaceuticals Inc | 655.00 | 68.74B | 14.25B | 4.58B | 3.88B | 41.77 | 
|   
                          
                                ALNY
                            
                             Alnylam Pharmaceuticals Inc | 451.91 | 58.93B | 2.46B | -319.09M | -52.09M | -2.4669 | 
|   
                          
                                ARGX
                            
                             Argen X Se Adr | 813.02 | 50.51B | 3.06B | 1.28B | 447.35M | 19.67 | 
|   
                          
                                INSM
                            
                             Insmed Inc | 190.00 | 41.29B | 398.11M | -1.03B | -868.57M | -5.7032 | 
Calcimedica Inc Stock (CALC) Latest News
Can CalciMedica Inc. recover in the next quarter2025 Key Lessons & Risk Controlled Stock Alerts - newser.com
Analyzing net buyer seller activity in CalciMedica Inc.2025 Institutional Moves & Consistent Profit Trade Alerts - newser.com
Regression analysis insights on CalciMedica Inc. performanceJuly 2025 Catalysts & Safe Entry Momentum Stock Tips - newser.com
Is CalciMedica Inc. stock near bottom after declinePortfolio Performance Report & Advanced Swing Trade Entry Alerts - newser.com
Best data tools to analyze CalciMedica Inc. stockMarket Sentiment Summary & Smart Investment Allocation Tips - newser.com
Is CalciMedica Inc. stock reversal real or fake2025 Trade Ideas & Real-Time Stock Movement Alerts - newser.com
Should I hold or sell CalciMedica Inc. stock in 2025July 2025 Review & Weekly Breakout Watchlists - newser.com
Is CalciMedica Inc. stock bottoming outProfit Target & AI Enhanced Trading Alerts - newser.com
Using data filters to optimize entry into CalciMedica Inc.Bond Market & Real-Time Stock Entry Alerts - newser.com
What MACD and RSI say about CalciMedica Inc.July 2025 Breakouts & Reliable Volume Spike Alerts - newser.com
Analyzing CalciMedica Inc. with risk reward ratio chartsQuarterly Market Summary & Reliable Price Action Trade Plans - newser.com
Technical signs of recovery in CalciMedica Inc.July 2025 Catalysts & Fast Gaining Stock Strategy Reports - newser.com
Detecting support and resistance levels for CalciMedica Inc.Weekly Trend Report & AI Forecasted Stock Moves - newser.com
Analyzing drawdowns of CalciMedica Inc. with statistical toolsEarnings Summary Report & Long-Term Capital Growth Ideas - newser.com
Published on: 2025-10-29 06:14:19 - newser.com
Is CalciMedica Inc. still worth holding after the dip2025 Macro Impact & Free Safe Entry Trade Signal Reports - newser.com
Published on: 2025-10-29 04:44:07 - newser.com
How to build a custom watchlist for CalciMedica Inc.Trade Ideas & AI Powered Market Entry Ideas - newser.com
Custom strategy builders for tracking CalciMedica Inc.Trade Exit Summary & Real-Time Market Sentiment Reports - newser.com
Comparing CalciMedica Inc. in custom built stock radarsTrade Risk Report & Fast Exit/Entry Strategy Plans - newser.com
CalciMedica Inc Stock Analysis and ForecastEconomic Indicators Overview & Superior Wealth Strategies - earlytimes.in
Is CalciMedica Inc. stock a safe haven assetPortfolio Return Report & Daily Profit Maximizing Tips - Fundação Cultural do Pará
What recovery options are there for CalciMedica Inc.Exit Point & Expert Approved Momentum Ideas - newser.com
Calcimedica’s Auxora Study: A Potential Game-Changer for AKI Treatment - TipRanks
Calcimedica Inc Stock (CALC) Financials Data
Revenue
Net Income
Cash Flow
EPS
Calcimedica Inc Stock (CALC) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | 
|---|---|---|---|---|---|---|---|
| Roberts Eric W | CHIEF BUSINESS OFFICER | Sep 15 '25 | Buy | 2.68 | 3,400 | 9,105 | 81,650 | 
| Roberts Eric W | CHIEF BUSINESS OFFICER | Sep 12 '25 | Buy | 3.12 | 5,000 | 15,600 | 78,250 | 
| Roberts Eric W | CHIEF BUSINESS OFFICER | Sep 09 '25 | Buy | 3.15 | 2,343 | 7,378 | 73,250 | 
| Roberts Eric W | CHIEF BUSINESS OFFICER | Aug 28 '25 | Buy | 2.86 | 9,200 | 26,340 | 70,107 | 
| Roberts Eric W | CHIEF BUSINESS OFFICER | Aug 29 '25 | Buy | 2.74 | 800 | 2,192 | 70,907 | 
| Roberts Eric W | CHIEF BUSINESS OFFICER | Aug 21 '25 | Buy | 2.79 | 3,508 | 9,797 | 60,907 | 
| Roberts Eric W | CHIEF BUSINESS OFFICER | Aug 20 '25 | Option Exercise | 1.53 | 15,000 | 22,950 | 179,706 | 
| Roberts Eric W | CHIEF BUSINESS OFFICER | Aug 20 '25 | Buy | 2.72 | 2,000 | 5,440 | 57,399 | 
| Roberts Eric W | CHIEF BUSINESS OFFICER | Aug 19 '25 | Buy | 2.79 | 1,000 | 2,790 | 55,399 | 
| Hebbar Sudarshan | Chief Medical Officer | Aug 19 '25 | Buy | 2.82 | 9,563 | 26,962 | 61,539 | 
        Open in Yahoo
        |
        Open in Google
            |
            Open in Finviz
        |
        Open in MarketWatch
            |
            Open in EDGAR    
        |
        Open in Reuters
    
    
                Cap:
                 
                  | 
                Volume (24h):
                 
            
         
                     
                             Get the Stockscreener App
                    Get the Stockscreener App